Abstract

Predicting the pathogenicity of biallelic missense variants can be challenging. Here, we use a deficit of observed homozygous carriers of missense variants, versus an expected number in a set of 153,054 chip-genotyped Icelanders, to identify potentially pathogenic genotypes. We follow three missense variants with a complete deficit of homozygosity and find that their pathogenic effect in homozygous state ranges from severe childhood disease to early embryonic lethality. One of these variants is in CPSF3, a gene not previously linked to disease. From a set of clinically sequenced Icelanders, and by sequencing archival samples targeted through the Icelandic genealogy, we find four homozygous carriers. Additionally, we find two homozygous carriers of Mexican descent of another missense variant in CPSF3. All six homozygous carriers of missense variants in CPSF3 show severe intellectual disability, seizures, microcephaly, and abnormal muscle tone. Here, we show how the absence of certain homozygous genotypes from a large population set can elucidate causes of previously unexplained recessive diseases and early miscarriage.

While the consequences of homozygous loss of function variants have been studied, the effect of missense variants is less understood. Here, the authors identify pathogenic genotypes through an observed deficit of homozygous carriers of missense variants in a population, elucidating previously unexplained recessive disease and miscarriage.

Details

Title
Population-level deficit of homozygosity unveils CPSF3 as an intellectual disability syndrome gene
Author
Arnadottir, Gudny A 1   VIAFID ORCID Logo  ; Oddsson Asmundur 2   VIAFID ORCID Logo  ; Jensson Brynjar O 2 ; Svanborg, Gisladottir 3   VIAFID ORCID Logo  ; Simon, Mariella T 4   VIAFID ORCID Logo  ; Arnthorsson, Asgeir O 2 ; Hildigunnur, Katrinardottir 2 ; Fridriksdottir Run 2 ; Ivarsdottir, Erna V 2   VIAFID ORCID Logo  ; Jonasdottir Adalbjorg 2 ; Jonasdottir Aslaug 2 ; Barrick, Rebekah 4 ; Jona, Saemundsdottir 2 ; le, Roux Louise 2   VIAFID ORCID Logo  ; Oskarsson, Gudjon R 2 ; Asmundsson Jurate 5 ; Steffensen Thora 5 ; Gudmundsson, Kjartan R 2 ; Ludvigsson Petur 6 ; Jonsson, Jon J 7 ; Masson Gisli 2 ; Jonsdottir Ingileif 1   VIAFID ORCID Logo  ; Holm Hilma 2   VIAFID ORCID Logo  ; Jonasson, Jon G 8 ; Magnusson, Olafur Th 2 ; Thorarensen Olafur 6 ; Abdenur Jose 4 ; Norddahl, Gudmundur L 2 ; Gudbjartsson, Daniel F 9   VIAFID ORCID Logo  ; Bjornsson, Hans T 10 ; Thorsteinsdottir Unnur 1 ; Sulem, Patrick 2   VIAFID ORCID Logo  ; Stefansson Kari 1   VIAFID ORCID Logo 

 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889); University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021) 
 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889) 
 The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842) 
 Children’s Hospital of Orange County, Division of Metabolic Disorders, Orange, USA (GRID:grid.414164.2) (ISNI:0000 0004 0442 4003) 
 The National University Hospital of Iceland, Department of Pathology, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842) 
 The National University Hospital of Iceland, Children’s Hospital Iceland, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842) 
 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842) 
 University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Pathology, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842) 
 deCODE Genetics/Amgen, Inc., Reykjavik, Iceland (GRID:grid.421812.c) (ISNI:0000 0004 0618 6889); University of Iceland, School of Engineering and Natural Sciences, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021) 
10  University of Iceland, Faculty of Medicine, Reykjavik, Iceland (GRID:grid.14013.37) (ISNI:0000 0004 0640 0021); The National University Hospital of Iceland, Department of Genetics and Molecular Medicine, Reykjavik, Iceland (GRID:grid.410540.4) (ISNI:0000 0000 9894 0842); Johns Hopkins University, Department of Genetic Medicine, Baltimore, USA (GRID:grid.21107.35) (ISNI:0000 0001 2171 9311) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2625413357
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.